A recent breakthrough by scientists in Israel has shed new light on a previously unknown function of the human immune system, potentially unlocking a new frontier in the fight against antibiotic-resistant bacteria. The study, led by Professor Yifat Merbl of the Weizmann Institute of Science, has revealed that a well-known cellular structure—the proteasome—does more than just recycle proteins. It also plays a surprising and powerful role in defending the body against bacterial infections.
For over a century, scientists have studied the human immune system, and public awareness of it has grown significantly—especially following the global COVID-19 pandemic five years ago. Yet, despite these advances, researchers have only now uncovered a critical, hidden layer of our body’s natural defense mechanisms. The proteasome, previously understood solely as a microscopic machine that breaks down and recycles damaged or unneeded proteins inside our cells, appears to have a second, entirely unrecognized purpose.
According to the study, the proteasome springs into action when a cell becomes infected by a pathogen such as Salmonella. Rather than simply disposing of broken proteins, it repurposes them into antimicrobial compounds. These newly formed molecules then attack and disrupt the outer membrane of invading bacteria, effectively killing them. This process represents a previously unknown mechanism of innate immunity.
“We discovered a novel mechanism of immunity that is allowing us to have a defense against bacterial infection,” Professor Merbl explained in an interview with BBC health correspondent James Gallagher. “It’s happening throughout our body in all the cells, and generates a whole new class of potential natural antibiotics.”
Once the researchers identified this remarkable immune function, they proceeded to test it in laboratory settings. In experiments with mice infected with pneumonia and sepsis, the team found that when the proteasome’s immune activity was disrupted, the mice became far more susceptible to infection. Conversely, when the natural immune peptides produced by the proteasome were present, they demonstrated antibiotic-like effects that rivaled existing drugs.
The implications of these findings are profound. Dr. Lindsey Edwards, a senior lecturer in microbiology at King’s College London, told the BBC that these naturally occurring compounds offer a unique advantage in the development of new antibiotics. “Because these proteasome-derived antimicrobials are made within us, any trials to test antibiotics based on these compounds would likely achieve safety requirements much faster,” she noted.
This discovery could not come at a more urgent time. Antibiotic resistance is considered one of the most pressing threats to global health. As bacteria evolve to evade traditional medications, new treatments are desperately needed. Most modern antibiotics have been discovered through decades of screening soil microbes or exploring exotic environments like ocean floors. But as Dr. Edwards pointed out, “In previous years it’s been digging up soil [to find new antibiotics], it is wild that it’s something we have within us, but comes down to having the technology to be able to detect these things.”
Now that this hidden function of the proteasome has been brought to light, researchers around the world may begin exploring how to harness it. Whether by synthesizing these naturally occurring immune peptides or finding ways to boost their activity within the body, this discovery could mark a significant turning point in the fight against superbugs.
The study not only deepens our understanding of human biology but also opens the door to a novel and potentially safer category of antibiotics. As the world continues to grapple with the growing danger of antibiotic resistance, innovations like this offer a much-needed glimmer of hope.
Recommended For You
